Form 8-K · Current report
Centene Corporation 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0001071739
- Accession no.
- 0001071739-26-000194
Summary
Centene reported third-quarter 2026 GAAP diluted loss per share of $(0.14) and adjusted diluted earnings per share of $0.58, with premium and service revenues of $45.1 billion and a health benefits ratio of 92.7%. The company raised its 2026 adjusted diluted EPS guidance floor to greater than $5.20 and lowered its full-year HBR guidance range to 90.4%–91.1%.
Key points
- Third-quarter 2026 total revenues were $50.647 billion, and premium and service revenues were $45.105 billion.
- Total at-risk membership was 25,698,200 at September 30, 2026, down from 27,968,100 a year earlier.
- Centene reduced debt by $1.1 billion since June 30, 2026, including the full redemption of its 2027 senior notes in October.
- Cash flow used in operations was $3.669 billion in the third quarter of 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION (a) On October 27, 2026, we issued a press release announcing our financial results for the third quarter ended September 30, 2026. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the website cited in the press release is not a part of this report. The information contained in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.